$CSX

Burns Michael S. sold $685K of CSX

Burns Michael S. (SVP - CLO & Corp Secy) sold 13,000 shares of CSX CORP (CSX) at $52.68 ($0.68M total) on 2026-07-24.

Original reporting
SEC EDGAR · Burns Michael S.
Published Jul 27, 2026, 8:15 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 27, 2026, 8:17 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CSX
Neutral
high confidence
Mentioned
$CSX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CSXNeutralLow
01

Why it matters

The disclosure updates insider trading records and may marginally influence sentiment, but it does not introduce new operational or financial information about CSX.

02

Market read

Traders may monitor insider activity, but this specific filing is unlikely to drive a durable repricing without accompanying fundamental news.

03

What to watch

No 10b5-1 plan is stated, but the article also lacks context on prior grants, option exercises, or total insider activity around the same period.

Relevance 5/10Novelty 3/10Timing: latest Form 4 filed 2026-07-27, covering sale dated 2026-07-24

Background

This is an SEC Form 4 insider transaction disclosure for CSX, reported by an officer (SVP - CLO & corporate secretary).

Company-level read

Ticker impact

$CSXNeutralHigh confidence
Context

CSX insider Michael S. Burns sold 13,000 shares on 2026-07-24 at $52.6800, totaling $684,840, per Form 4.

Expected impact

Likely limited near-term impact; could slightly weigh on sentiment but lacks fundamental new company information.

Evidence & confidence

The filing discloses a single insider sale size and price, but provides no earnings, guidance, deal, or regulatory catalyst that would change CSX fundamentals.

Market effects

Minimal; insider sale does not signal sector-wide change for railroads.

None indicated.

None indicated.

Counterpoint

The sale may be driven by diversification, taxes, or pre-existing personal liquidity needs rather than a bearish view on CSX.

Key entities

  • CSX

    CSX Corp, the company whose insider transaction is reported.

  • Michael S. Burns

    SVP - CLO & corporate secretary who sold 13,000 CSX shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NSCMedAI 8/10

Rail Merger Faces More Headwinds As Port Of Mobile Objects

The $85B merger between Union Pacific (UNP) and Norfolk Southern (NSC) faces delays and opposition. The Port of Mobile, citing potential economic harm, plans to submit comments. Rival railroads (BNSF, CSX, CPKC) object to repeated data corrections in the merger proposal, calling for a halt to further changes.

$CSXMed

BNSF, CPKC, and CSX to request broad access to a combined UP

BNSF, CPKC, and CSX plan to request extensive trackage rights over a combined Union Pacific-Norfolk Southern system, if regulators approve their $85 billion merger. The railroads argue the merger will harm competition and the economy. BNSF seeks 824 miles of trackage rights between Chicago and Pennsylvania, while CPKC targets the Kansas City-St. Louis corridor and other routes. CSX also aims for access to the Kansas City-St. Louis trackage.

$CSXMed

CSX (CSX) Earnings Beat Leaves Its Valuation Question Open

CSX reported Q2 FY2026 earnings exceeding Wall Street estimates, with revenue and adjusted EPS above expectations. Shares have seen a 90-day return of 4.88% and a YTD return of 36.23%. The stock's fair value is estimated at $52.85, slightly above its last close of $49.41, with a P/E ratio of 28.4x, leaving valuation debates open.

$AAPLHighAI 8/10

Why Did AAPL, QTTB, CSX Stocks Surge To 52-Week Highs Today?

Apple (AAPL), Q32 Bio (QTTB), and CSX Corp. (CSX) reached 52-week highs. AAPL rose 0.6% to $323.45; Citi raised its target to $365. QTTB surged 90% after positive clinical data; Wells Fargo upgraded it to 'Overweight' with a $66 target. CSX gained 0.4% to $49.90; Raymond James lifted its target to $56. Year-to-date gains: AAPL +16%, CSX +36%, QTTB +543%.

$CSXMedAI 8/10

Bank of America Securities Remains a Buy on CSX (CSX)

Bank of America Securities maintained a Buy rating on CSX with a $56 price target. Wells Fargo also recommended Buy, while Bernstein advised Hold. CSX reported Q2 revenue of $3.94B and net profit of $1B, up from last year. Insider sentiment is negative, with increased selling activity.